Transitioning from Strattera to Concerta in Adolescents
Initial Dosing and Titration
- The American Academy of Child and Adolescent Psychiatry recommends starting with Concerta 18mg once daily in the morning, which is approximately equivalent to methylphenidate immediate-release 5mg given three times daily 1
- Concerta utilizes an osmotically released, timed drug-delivery system (OROS) that produces an ascending plasma drug level throughout the day with effects lasting for a full 12-hour period 2
- Morning administration is recommended to minimize potential sleep disturbances 2
- After starting with 18mg, assess clinical response after 1 week 1
- If needed, increase to 36mg once daily, then potentially to 54mg once daily based on clinical response 2
- Clinical efficacy should guide dosing rather than weight or plasma concentrations, as plasma levels of methylphenidate do not correlate well with clinical response 1
Monitoring and Managing Side Effects
- Monitor for common side effects of Concerta, including decreased appetite 3
- Potential changes in heart rate and blood pressure should be monitored 4
- Watch for emergence of tics, which can occur with stimulant medications 5
- For appetite loss: administer Concerta with meals and provide a high-calorie snack in the evening when stimulant effects have worn off 3
- For difficulty falling asleep: ensure morning administration of Concerta and consider implementing a bedtime routine 3
- For irritability: evaluate when it occurs (peak effect vs. rebound) and adjust dosing accordingly 3
Special Considerations and Efficacy Expectations
- Concerta has several advantages over immediate-release methylphenidate, including eliminating the midday "trough" in medication levels 1
- Concerta has a lower potential for abuse compared to immediate-release formulations 1
- Once-daily dosing improves compliance, particularly important for adolescents 2
- If oral tics develop while on Concerta, consider adjusting the dose of Concerta or adding an alpha-agonist such as clonidine or guanfacine as a first-line option for managing tics 5
- Allow at least 1-2 weeks to evaluate the initial response to Concerta 2